Moderna says new Covid vaccine was effective against Eris variant in early trial

Moderna says new Covid vaccine was effective against Eris variant in early trial


Nikos Pekiaridis | Lightrocket | Getty Images

Moderna’s new Covid vaccine generated a robust immune response against the now-dominant “Eris” variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. 

The updated shot is designed to target omicron subvariant XBB.1.5, but the results suggest that the jab may still be effective against newer variants of the virus that are gaining ground nationwide. That includes Eris and another variant nicknamed “Fornax” – both of which are also descendants of the omicron virus variant. 

Moderna’s vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration. 

Meanwhile Covid-related hospitalizations fueled by Eris and other variants continue to accelerate, though remain below the summer peak that strained hospitals this time last year.

Eris, also known as EG.5, accounted for 17.3% of all cases as of earlier this month, according to the Centers for Disease Control and Prevention. 

The World Health Organization designated Eris a “variant of interest,” meaning it will be monitored for mutations that could make it more severe. 

Fornax, or FL 1.5.1, is also beginning to surge in parts of the U.S. It accounted for 8.6% of all cases nationwide as of earlier this month, the CDC said.



Source

What wealthy parents need to know about giving real estate to their kids
Business

What wealthy parents need to know about giving real estate to their kids

A local house with a porch in Edgartown on Martha’s Vineyard, Massachusetts, USA. Wolfgang Kaehler | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. The great wealth […]

Read More
The summer box office sizzled, but brace for a cooldown until November
Business

The summer box office sizzled, but brace for a cooldown until November

Movie stills from Disney’s “Lilo & Stitch” and “Fantastic Four” and Warner Bros. Discovery’s “Superman.” Courtesy: Disney | 20th Century Studios | Marvel Studios | Warner Bros. Discovery Superheroes, dinosaurs and a genetically altered alien dog helped propel the summer box office haul above 2024 levels, but that momentum is about to stall. Heading into […]

Read More
John Deere faces a crossroads amid decreasing demand, increasing investments
Business

John Deere faces a crossroads amid decreasing demand, increasing investments

Attendees view a John Deere 7R 270 row crop tractor at the Deere & Co. booth during the World Ag Expo at the International Agri-Center in Tulare, California on February 11, 2025. Patrick T. Fallon | AFP | Getty Images John Deere is facing a crossroads as the company continues to see weaker demand in […]

Read More